Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)

Journal of Human Genetics

Volumn 48, Issue 5, 2003, Pages 226-230

  Lazar, Andreas ^a   Gründemann, Dirk ^a   Berkels, Reinhard ^a   Taubert, Dirk ^a   Zimmermann, Tim ^a   Schömig, Edgar ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Caucasians; EMT; Frequency of polymorphisms; SLC22A3; SNP

Indexed keywords

3' UNTRANSLATED REGION; ADRENERGIC SYSTEM; ARTICLE; BINDING SITE; CATECHOLAMINE RELEASE; CAUCASIAN; EMT GENE; EXON; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; NEUROPSYCHIATRY; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0037632843     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10038-003-0015-5     Document Type: Article

References (37)

1. Arner P (2001) Genetic variance and lipolysis regulation: implications for obesity. Ann Med 33:542-546
2. Brunner HG, Nelen M, Breakefield XO, Ropers HH, Oost BA van (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578-580
3. Bugajski J, Borycz J, Gadek-Michalska A (1998) Involvement of the central noradrenergic system in cholinergic stimulation of the pituitary-adrenal response. J Physiol Pharmacol 49:285-292
4. Chen ZP, Wang G, Huang Q, Sun ZF, Zhou LY, Wang AD, Panasci LC (1999) Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model. J Neurooncol 44:7-14
5. Dunnen JT den, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
6. Eisenhofer G (2001) The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35-62
7. Graefe KH, Friedgen B, Wolfel R, Schömig E (1998) Removal of circulating catecholamines by extraneuronal amine transport systems. Adv Pharmacol 42:360-363
8. Gründemann D, Schömig E (1996) Protection of DNA during preparative agarose gel electrophoresis against damage induced by ultraviolet light. Biotechniques 21:898-903
9. Gründemann D, Schömig E (2000) Gene structures of the human non-neuronal monoamine transporters EMT and OCT2. Hum Genet 106:627-635
10. Gründemann D, Schechinger B, Rappold GA, Schömig E (1998) Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349-351
11. Halushka MK, Fan JB, Bentley K, Hsie L, Shen N, Weder A, Cooper R, Lipshutz R, Chakravarti A (1999) Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247
12. Hill WG, Robertson A (1968) Linkage disequilibrium in finite populations. Theor Appl Genet 38:226-231
13. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26:163-175
14. International SNP Map Working Group (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933
15. Iversen LL (1965) The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process. Br J Pharmacol 25:18-33
16. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Clark AG, Herskowitz I, Giacomini KM (2002) Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 12:395-405
17. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531
18. Lewontin RC (1984) The interaction of selection and linkage, I. General considerations; heterotic models. Genetics 49:49-67
19. Lewontin RC, Kojima K (1960) The evolutionary dynamics of complex polymorphisms. Evolution 14:450-472
20. Mark AL (1996) The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 14:S159-S165
21. Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S (2002) Dopamine transport function is elevated in cocaine users. J Neurochem 81:292-300
22. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354
23. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355
24. Rozas J, Rozas R (1999) DnaSP version 3: an integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics 15:174-175
25. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD (2000) Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension 36:824-829
26. Russ H, Staust K, Martel F, Gliese M, Schömig E (1996) The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256-1264
27. Saito S, Iida A, Sekine A, Ogawa C, Kawauchi S, Higuchi S, Nakamura Y (2002) Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in the Japanese population. J Hum Genet 47:576-584
28. Sanders VM, Straub RH (2002) Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behav Immun 16:290-332
29. Schömig E, Russ H, Staudt K, Martel F, Gliese M, Gründemann D (1998) The extraneuronal monoamine transporter exists in human central nervous system glia. Adv Pharmacol 42:356-359
30. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342:541-549
31. Simonsen KL, Churchill GA, Aquadro CF (1995) Properties of statistical tests of neutrality for DNA polymorphism data. Genetics 141:413-429
32. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF (2001) Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489-493
33. Strachan T, Read AP (1999) Human molecular genetics, 2nd edn. BIOS, Oxford
34. Tajima F (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123:585-595
35. Terwilliger J, Ott J (1994) Handbook of human genetic linkage. Johns Hopkins University Press, Baltimore
36. Wooten GF, Trugman JM (1989) The dopamine motor system. Mov Disord 4:S38-S47
37. Xie X, Ott J (1993) Testing linkage disequilibrium between a disease gene and marker loci (abstract). Am J Hum Genet 53:1107